Skip to main content
Top
Published in: Familial Cancer 1/2016

01-01-2016 | Short Communication

First report of somatic mosaicism for mutations in STK11 in four patients with Peutz–Jeghers syndrome

Authors: Victoria McKay, Diane Cairns, David Gokhale, Roger Mountford, Lynn Greenhalgh

Published in: Familial Cancer | Issue 1/2016

Login to get access

Abstract

Peutz–Jeghers syndrome (PJS) is an autosomal dominant cancer predisposition syndrome characterised by gastrointestinal polyposis and mucocutaneous pigmentation. Mutations in STK11, a serine–threonine protein kinase, have been associated with PJS in up to 100 % of published series. The hypothesis that a further genetic locus for PJS exists is controversial. No mutations in any other genes have been described in association with PJS. To date, no instances of somatic mosaicism for STK11 have been described. DNA extracted from peripheral lymphocytes and buccal cells was screened by sequence analysis for mutations in STK11. Dosage analysis was undertaken by multiplex ligation-dependent probe amplification (MLPA). Four patients have been shown to have mosaicism in STK11: two had mosaic deletions of specific exons (2–3 and 3–10) of the STK11 gene; one had a mosaic nonsense mutation in exon 5; and one had a mosaic frameshift mutation in exon 8. This report details the first four reported cases of somatic mosaicism for STK11 associated with PJS. This shows that techniques in addition to direct sequencing such as MLPA must be used to assess for large scale genomic deletions in patients meeting clinical diagnostic criteria for PJS. This also adds further weight to the hypothesis of a single genetic locus for PJS.
Literature
1.
go back to reference McGarrity TJ, Amos CI, Frazier ML, McGarrity TJ, Amos CI, Frazier ML, Wei C (2001) Peutz–Jeghers syndrome. In: Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH, Bird TD, Dolan CR, Fong CT, Smith RJH, Stephens K (eds) GeneReviews® [Internet], University of Washington, Seattle [updated 2013 Jul 25] McGarrity TJ, Amos CI, Frazier ML, McGarrity TJ, Amos CI, Frazier ML, Wei C (2001) Peutz–Jeghers syndrome. In: Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH, Bird TD, Dolan CR, Fong CT, Smith RJH, Stephens K (eds) GeneReviews® [Internet], University of Washington, Seattle [updated 2013 Jul 25]
2.
go back to reference Amos CI, Keitheri-Cheteri MB, Sabripour M, Wei C, McGarrity TJ, Seldin MF, Nations L, Lynch PM, Fidder HH, Friedman E, Frazier ML (2004) Genotype–phenotype correlations in Peutz–Jeghers syndrome. J Med Genet 41(5):327–333PubMedPubMedCentralCrossRef Amos CI, Keitheri-Cheteri MB, Sabripour M, Wei C, McGarrity TJ, Seldin MF, Nations L, Lynch PM, Fidder HH, Friedman E, Frazier ML (2004) Genotype–phenotype correlations in Peutz–Jeghers syndrome. J Med Genet 41(5):327–333PubMedPubMedCentralCrossRef
3.
go back to reference Boardman LA, Thibodeau SN, Schaid DJ, Lindor NM, McDonnell SK, Burgart LJ, Ahlquist DA, Podratz KC, Pittelkow M, Hartmann LC (1998) Increased risk for cancer in patients with the Peutz–Jeghers syndrome. Ann Intern Med 128(11):896–899PubMedCrossRef Boardman LA, Thibodeau SN, Schaid DJ, Lindor NM, McDonnell SK, Burgart LJ, Ahlquist DA, Podratz KC, Pittelkow M, Hartmann LC (1998) Increased risk for cancer in patients with the Peutz–Jeghers syndrome. Ann Intern Med 128(11):896–899PubMedCrossRef
4.
go back to reference Young RH (2005) Sex cord-stromal tumors of the ovary and testis: their similarities and differences with consideration of selected problems. Mod Pathol 18(Suppl 2):S81–S98PubMedCrossRef Young RH (2005) Sex cord-stromal tumors of the ovary and testis: their similarities and differences with consideration of selected problems. Mod Pathol 18(Suppl 2):S81–S98PubMedCrossRef
5.
go back to reference Beggs AD, Latchford AR, Vasen HF, Moslein G, Alonso A, Aretz S, Bertario L, Blanco I, Bülow S, Burn J, Capella G, Colas C, Friedl W, Møller P, Hes FJ, Järvinen H, Mecklin JP, Nagengast FM, Parc Y, Phillips RK, Hyer W, Ponz de Leon M, Renkonen-Sinisalo L, Sampson JR, Stormorken A, Tejpar S, Thomas HJ, Wijnen JT, Clark SK, Hodgson SV (2010) Peutz–Jeghers syndrome: a systematic review and recommendations for management. Gut 9(7):975–986CrossRef Beggs AD, Latchford AR, Vasen HF, Moslein G, Alonso A, Aretz S, Bertario L, Blanco I, Bülow S, Burn J, Capella G, Colas C, Friedl W, Møller P, Hes FJ, Järvinen H, Mecklin JP, Nagengast FM, Parc Y, Phillips RK, Hyer W, Ponz de Leon M, Renkonen-Sinisalo L, Sampson JR, Stormorken A, Tejpar S, Thomas HJ, Wijnen JT, Clark SK, Hodgson SV (2010) Peutz–Jeghers syndrome: a systematic review and recommendations for management. Gut 9(7):975–986CrossRef
6.
go back to reference Riegert-Johnson D, Gleeson FC, Westra W, Hefferon T, Wong Kee Song LM, Spurck L, Boardman LA (2008) Peutz–Jeghers syndrome. In: Riegert-Johnson DL, Boardman LA, Hefferon T, Roberts M (eds) Cancer syndromes [Internet], National Center for Biotechnology Information, Bethesda [updated 2008 Aug 09] Riegert-Johnson D, Gleeson FC, Westra W, Hefferon T, Wong Kee Song LM, Spurck L, Boardman LA (2008) Peutz–Jeghers syndrome. In: Riegert-Johnson DL, Boardman LA, Hefferon T, Roberts M (eds) Cancer syndromes [Internet], National Center for Biotechnology Information, Bethesda [updated 2008 Aug 09]
7.
go back to reference Collins SP, Reoma JL, Gamm DM, Uhler MD (2000) LKB1, a novel serine/threonine protein kinase and potential tumour suppressor, is phosphorylated by cAMP-dependent protein kinase (PKA) and prenylated in vivo. Biochem J 345(Pt 3):673–680PubMedPubMedCentralCrossRef Collins SP, Reoma JL, Gamm DM, Uhler MD (2000) LKB1, a novel serine/threonine protein kinase and potential tumour suppressor, is phosphorylated by cAMP-dependent protein kinase (PKA) and prenylated in vivo. Biochem J 345(Pt 3):673–680PubMedPubMedCentralCrossRef
8.
go back to reference Borun P, Bartkowiak A, Banasiewicz T, Nedoszytko B, Nowakowska D, Teisseyre M, Limon J, Lubinski J, Kubaszewski L, Walkowiak J, Czkwianianc E, Siolek M, Kedzia A, Krokowicz P, Cichy W, Plawski A (2013) High resolution melting analysis as a rapid and efficient method of screening for small mutations in the STK11 gene in patients with Peutz–Jeghers syndrome. BMC Med Genet 14:58PubMedPubMedCentralCrossRef Borun P, Bartkowiak A, Banasiewicz T, Nedoszytko B, Nowakowska D, Teisseyre M, Limon J, Lubinski J, Kubaszewski L, Walkowiak J, Czkwianianc E, Siolek M, Kedzia A, Krokowicz P, Cichy W, Plawski A (2013) High resolution melting analysis as a rapid and efficient method of screening for small mutations in the STK11 gene in patients with Peutz–Jeghers syndrome. BMC Med Genet 14:58PubMedPubMedCentralCrossRef
9.
go back to reference Smith DP, Spicer J, Smith A, Swift S, Ashworth A (1999) The mouse Peutz–Jeghers syndrome gene Lkb1 encodes a nuclear protein kinase. Hum Mol Genet 8(8):1479–1485PubMedCrossRef Smith DP, Spicer J, Smith A, Swift S, Ashworth A (1999) The mouse Peutz–Jeghers syndrome gene Lkb1 encodes a nuclear protein kinase. Hum Mol Genet 8(8):1479–1485PubMedCrossRef
10.
go back to reference Jenne DE, Reimann H, Nezu J, Friedel W, Loff S, Jeschke R, Müller O, Back W, Zimmer M (1998) Peutz–Jeghers syndrome is caused by mutations in a novel serine threonine kinase. Nat Genet 18(1):38–43PubMedCrossRef Jenne DE, Reimann H, Nezu J, Friedel W, Loff S, Jeschke R, Müller O, Back W, Zimmer M (1998) Peutz–Jeghers syndrome is caused by mutations in a novel serine threonine kinase. Nat Genet 18(1):38–43PubMedCrossRef
11.
go back to reference Hemminki A, Markie D, Tomlinson I, Avizienyte E, Roth S, Loukola A, Bignell G, Warren W, Aminoff M, Höglund P, Järvinen H, Kristo P, Pelin K, Ridanpää M, Salovaara R, Toro T, Bodmer W, Olschwang S, Olsen AS, Stratton MR, de la Chapelle A, Aaltonen LA (1998) A serine/threonine kinase gene defective in Peutz–Jeghers syndrome. Nature 391(6663):184–187PubMedCrossRef Hemminki A, Markie D, Tomlinson I, Avizienyte E, Roth S, Loukola A, Bignell G, Warren W, Aminoff M, Höglund P, Järvinen H, Kristo P, Pelin K, Ridanpää M, Salovaara R, Toro T, Bodmer W, Olschwang S, Olsen AS, Stratton MR, de la Chapelle A, Aaltonen LA (1998) A serine/threonine kinase gene defective in Peutz–Jeghers syndrome. Nature 391(6663):184–187PubMedCrossRef
12.
go back to reference Ylikorkala A, Avizienyte E, Tomlinson IP, Tiainen M, Roth S, Loukola A, Hemminki A, Johansson M, Sistonen P, Markie D, Neale K, Phillips R, Zauber P, Twama T, Sampson J, Järvinen H, Mäkelä TP, Aaltonen LA (1999) Mutations and impaired function of LKB1 in familial and non-familial Peutz–Jeghers syndrome and a sporadic testicular cancer. Hum Mol Genet 8(1):45–51PubMedCrossRef Ylikorkala A, Avizienyte E, Tomlinson IP, Tiainen M, Roth S, Loukola A, Hemminki A, Johansson M, Sistonen P, Markie D, Neale K, Phillips R, Zauber P, Twama T, Sampson J, Järvinen H, Mäkelä TP, Aaltonen LA (1999) Mutations and impaired function of LKB1 in familial and non-familial Peutz–Jeghers syndrome and a sporadic testicular cancer. Hum Mol Genet 8(1):45–51PubMedCrossRef
13.
go back to reference de Leng WW, Jansen M, Carvalho R, Polak M, Musler AR, Milne AN, Keller JJ, Menko FH, de Rooij FW, Iacobuzio-Donahue CA, Giardiello FM, Weterman MA, Offerhaus GJ (2007) Genetic defects underlying Peutz–Jeghers syndrome (PJS) and exclusion of the polarity-associated MARK/Par1 gene family as potential PJS candidates. Clin Genet 72(6):568–573PubMedPubMedCentralCrossRef de Leng WW, Jansen M, Carvalho R, Polak M, Musler AR, Milne AN, Keller JJ, Menko FH, de Rooij FW, Iacobuzio-Donahue CA, Giardiello FM, Weterman MA, Offerhaus GJ (2007) Genetic defects underlying Peutz–Jeghers syndrome (PJS) and exclusion of the polarity-associated MARK/Par1 gene family as potential PJS candidates. Clin Genet 72(6):568–573PubMedPubMedCentralCrossRef
14.
go back to reference Le Meur N, Martin C, Saugier-Veber P, Joly G, Lemoine F, Moirot H, Rossi A, Bachy B, Cabot A, Joly P, Frébourg T (2004) Complete germline deletion of the STK11 gene in a family with Peutz–Jeghers syndrome. Eur J Hum Genet 12(5):415–418PubMedCrossRef Le Meur N, Martin C, Saugier-Veber P, Joly G, Lemoine F, Moirot H, Rossi A, Bachy B, Cabot A, Joly P, Frébourg T (2004) Complete germline deletion of the STK11 gene in a family with Peutz–Jeghers syndrome. Eur J Hum Genet 12(5):415–418PubMedCrossRef
15.
go back to reference Papp J, Kovacs ME, Solyom S, Kasler M, Børresen-Dale AL, Olah E (2010) High prevalence of germline STK11 mutations in Hungarian Peutz–Jeghers Syndrome patients. BMC Med Genet 11:169PubMedPubMedCentralCrossRef Papp J, Kovacs ME, Solyom S, Kasler M, Børresen-Dale AL, Olah E (2010) High prevalence of germline STK11 mutations in Hungarian Peutz–Jeghers Syndrome patients. BMC Med Genet 11:169PubMedPubMedCentralCrossRef
16.
go back to reference Volikos E, Robinson J, Aittomäki K, Mecklin JP, Järvinen H, Westerman AM, de Rooji FW, Vogel T, Moeslein G, Launonen V, Tomlinson IP, Silver AR, Aaltonen LA (2006) LKB1 exonic and whole gene deletions are a common cause of Peutz–Jeghers syndrome. J Med Genet 43(5):e18PubMedPubMedCentralCrossRef Volikos E, Robinson J, Aittomäki K, Mecklin JP, Järvinen H, Westerman AM, de Rooji FW, Vogel T, Moeslein G, Launonen V, Tomlinson IP, Silver AR, Aaltonen LA (2006) LKB1 exonic and whole gene deletions are a common cause of Peutz–Jeghers syndrome. J Med Genet 43(5):e18PubMedPubMedCentralCrossRef
17.
go back to reference Hearle N, Schumacher V, Menko FH, Olschwang S, Boardman LA, Gille JJ, Keller JJ, Westerman AM, Scott RJ, Lim W, Trimbath JD, Giardiello FM, Gruber SB, Offerhaus GJ, Rooij FW, Wilson JH, Hansmann A, Möslein G, Royer-Pokora B, Vogel T, Phillips RK, Spigelman AD, Houlston RS (2006) STK11 status and intussusception risk in Peutz–Jeghers syndrome. J Med Genet 43(8):e41PubMedPubMedCentralCrossRef Hearle N, Schumacher V, Menko FH, Olschwang S, Boardman LA, Gille JJ, Keller JJ, Westerman AM, Scott RJ, Lim W, Trimbath JD, Giardiello FM, Gruber SB, Offerhaus GJ, Rooij FW, Wilson JH, Hansmann A, Möslein G, Royer-Pokora B, Vogel T, Phillips RK, Spigelman AD, Houlston RS (2006) STK11 status and intussusception risk in Peutz–Jeghers syndrome. J Med Genet 43(8):e41PubMedPubMedCentralCrossRef
18.
go back to reference Buchet-Poyau K, Mehenni H, Radhakrishna U, Antonarakis SE (2002) Search for the second Peutz–Jeghers syndrome locus: exclusion of the STK13, PRKCG, KLK10, and PSCD2 genes on chromosome 19 and the STK11IP gene on chromosome 2. Cytogenet Genome Res 97(3–4):171–178PubMedCrossRef Buchet-Poyau K, Mehenni H, Radhakrishna U, Antonarakis SE (2002) Search for the second Peutz–Jeghers syndrome locus: exclusion of the STK13, PRKCG, KLK10, and PSCD2 genes on chromosome 19 and the STK11IP gene on chromosome 2. Cytogenet Genome Res 97(3–4):171–178PubMedCrossRef
19.
go back to reference Leggett BA, Young JP, Barker M (2003) Peutz–Jeghers syndrome: genetic screening. Expert Rev Anticancer Ther 3(4):518–524PubMedCrossRef Leggett BA, Young JP, Barker M (2003) Peutz–Jeghers syndrome: genetic screening. Expert Rev Anticancer Ther 3(4):518–524PubMedCrossRef
20.
go back to reference Scott RJ, Crooks R, Meldrum CJ, Thomas L, Smith CJ, Mowat D, McPhillips M, Spigelman AD (2002) Mutation analysis of the STK11/LKB1 gene and clinical characteristics of an Australian series of Peutz–Jeghers syndrome patients. Clin Genet 62(4):282–287PubMedCrossRef Scott RJ, Crooks R, Meldrum CJ, Thomas L, Smith CJ, Mowat D, McPhillips M, Spigelman AD (2002) Mutation analysis of the STK11/LKB1 gene and clinical characteristics of an Australian series of Peutz–Jeghers syndrome patients. Clin Genet 62(4):282–287PubMedCrossRef
Metadata
Title
First report of somatic mosaicism for mutations in STK11 in four patients with Peutz–Jeghers syndrome
Authors
Victoria McKay
Diane Cairns
David Gokhale
Roger Mountford
Lynn Greenhalgh
Publication date
01-01-2016
Publisher
Springer Netherlands
Published in
Familial Cancer / Issue 1/2016
Print ISSN: 1389-9600
Electronic ISSN: 1573-7292
DOI
https://doi.org/10.1007/s10689-015-9839-3

Other articles of this Issue 1/2016

Familial Cancer 1/2016 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine